Article Versions Notes

Vessières A, Quissac E, Lemaire N, Alentorn A, Domeracka P, Pigeon P, Sanson M, Idbaih A, Verreault M. Heterogeneity of Response to Iron-Based Metallodrugs in Glioblastoma Is Associated with Differences in Chemical Structures and Driven by FAS Expression Dynamics and Transcriptomic Subtypes. International Journal of Molecular Sciences. 2021; 22(19):10404. https://doi.org/10.3390/ijms221910404

Vessières, Anne, Emie Quissac, Nolwenn Lemaire, Agusti Alentorn, Patrycja Domeracka, Pascal Pigeon, Marc Sanson, Ahmed Idbaih, and Maïté Verreault. 2021. "Heterogeneity of Response to Iron-Based Metallodrugs in Glioblastoma Is Associated with Differences in Chemical Structures and Driven by FAS Expression Dynamics and Transcriptomic Subtypes" International Journal of Molecular Sciences 22, no. 19: 10404. https://doi.org/10.3390/ijms221910404

Vessières, A., Quissac, E., Lemaire, N., Alentorn, A., Domeracka, P., Pigeon, P., Sanson, M., Idbaih, A., & Verreault, M. (2021). Heterogeneity of Response to Iron-Based Metallodrugs in Glioblastoma Is Associated with Differences in Chemical Structures and Driven by FAS Expression Dynamics and Transcriptomic Subtypes. International Journal of Molecular Sciences, 22(19), 10404. https://doi.org/10.3390/ijms221910404